News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Phadia AB Announces First-Ever Commercial Availability of Peanut Allergen Component Tests



8/16/2011 10:31:29 AM

PORTAGE, Mich.--(BUSINESS WIRE)--Today Phadia, the global leader in allergy and autoimmune disease-related diagnostics, announced that the uKnow Peanut Test, its peanut allergen component test, is now commercially available in the United States through the Phadia Immunology Reference Laboratory (PiRLĀ®). FDA clearance of the individual peanut component tests, announced in May 2011, brings these cutting-edge new in vitro allergy tests to clinicians nationwide. The uKnow Peanut Test reports specific IgE results to five FDA cleared peanut allergen components in addition to carbohydrate cross-reactive determinants, a laboratory developed test.

Read at BioSpace.com


comments powered by Disqus
Phadia AB
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES